Skip to main content
Clinical Trials/NCT03874598
NCT03874598
Completed
Not Applicable

Effectiveness of Ear Acupuncture to Improve Insomnia in Women With Breast Cancer: a Randomized Controlled Trial

Universität Duisburg-Essen1 site in 1 country52 target enrollmentJune 12, 2019
ConditionsBreast Neoplasm

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Neoplasm
Sponsor
Universität Duisburg-Essen
Enrollment
52
Locations
1
Primary Endpoint
Sleep Quality
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The aim of this clinical study is to investigate the extent to which ear acupuncture has an effect on insomnia in women with breast cancer. It will be investigated whether changes in sleep quality, fatigue, quality of life, stress, and psychological well-being can be achieved. In addition, a proinflammatory cytokine will be meassured.

Registry
clinicaltrials.gov
Start Date
June 12, 2019
End Date
February 19, 2020
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Dr. med. Petra Voiss

MD

Universität Duisburg-Essen

Eligibility Criteria

Inclusion Criteria

  • Histological diagnosed non-metastatic breast CAs (TNM stage I-III)
  • Existing insomnia (difficulty falling asleep or sleeping through on at least 3 days per week for at least 3 months) according to the diagnostic criteria of the Diagnostic and Statistical Manual of Mental Disorders (DSM 5).
  • willingness to participate in the study (at least 8 out of 10 treatments)
  • Signed informed consent

Exclusion Criteria

  • Ongoing or planned chemotherapy, radiation, follow-up treatment or reconstructive plastic surgery during the study period
  • Severe physical or psychopharmacologically treated psychiatric comorbidity that prevents a patient from participating in the study
  • Pregnancy
  • Participation in other clinical trials with behavioural, psychological or complementary medical interventions during the study period
  • Regular use of barbiturates, antidepressants or other sleep-inducing drugs, drug abusus, alcoholism

Outcomes

Primary Outcomes

Sleep Quality

Time Frame: week 5

Pittsburgh Sleep Quality Index (PSQI). The PSQI contains 19 self-assessment questions and 5 questions rated by the bed-partner or roommate. The 5 questions rated by the bed-partner or roommate are only used as clinical information and not included in qualitative analysis. The question whether a bed-partner or roommate is present is not included in qualitative analysis as well. The 18 self-assessment items are used to evaluate the sleep quality on 7 domains over the last month (subjective sleep quality, sleep latency, sleep duration, habitual sleep efficiency, and sleep disturbances, use of sleep medication, and daytime dysfunction). Scoring of the answers is based on a scale from 0 to 3, whereby 3 reflects the negative extreme on a Likert Scale. The total score is generated by the summation of the component scores and can vary from 0 to 21, with a higher score corresponding to a reduced sleep quality. A cut-off score of 5 indicates a "poor" sleeper.

Secondary Outcomes

  • Quality of Life in cancer patients(week 29)
  • Fatigue(week 29)
  • Psychological well-being(week 29)
  • Stress(week 29)
  • Adverse Events(week 17)
  • Change in proinflammatory cytokine(week 5)
  • Expectation(week 0)
  • Sleep Quality(week 29)

Study Sites (1)

Loading locations...

Similar Trials